Chemical activators of SSXB9 include a variety of compounds that initiate a cascade of intracellular events leading to the protein's activation through phosphorylation. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), and upon PMA exposure, PKC becomes active and can directly phosphorylate SSXB9. Similarly, Forskolin, by increasing intracellular cyclic AMP (cAMP) levels, indirectly activates protein kinase A (PKA). PKA then can phosphorylate SSXB9, thereby enhancing its activity. Ionomycin, through its capacity to increase intracellular calcium levels, can engage calcium-sensitive kinases, which, in turn, phosphorylate and activate SSXB9. Thapsigargin acts in a similar manner by elevating cytosolic calcium, which activates kinases that are capable of phosphorylating SSXB9.
Isoproterenol and Epinephrine both function by binding to beta-adrenergic receptors, leading to increased levels of cAMP within the cell and subsequent activation of PKA, which then phosphorylates SSXB9. Anisomycin activates stress-activated protein kinases (SAPKs), which are also capable of phosphorylating SSXB9, resulting in its activation. Dibutyryl-cAMP and 8-Br-cAMP are cAMP analogs that activate PKA, promoting the phosphorylation of SSXB9. Okadaic Acid and Calyculin A are known to inhibit protein phosphatases such as PP1 and PP2A; the inhibition by these compounds prevents the dephosphorylation of SSXB9, effectively maintaining its phosphorylated and active state. Each chemical, through its unique mode of action, ensures the activation of SSXB9 by either directly phosphorylating it or by maintaining its phosphorylation status, crucial for its functional activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which then phosphorylates SSXB9, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium, which activates calcium-dependent kinases that phosphorylate and activate SSXB9. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin elevates cytosolic calcium levels, activating kinases that can phosphorylate and activate SSXB9. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol binds to beta-adrenergic receptors, raising cAMP levels, thereby activating PKA which phosphorylates and activates SSXB9. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
By interacting with adrenergic receptors, Epinephrine increases cAMP, which activates PKA leading to the phosphorylation and activation of SSXB9. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which can phosphorylate and lead to the activation of SSXB9. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP mimics cAMP to activate PKA, which can phosphorylate and thus activate SSXB9. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP serves as a cAMP analog to activate PKA, leading to the phosphorylation and activation of SSXB9. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, maintaining the phosphorylation and activation state of SSXB9. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits phosphatases that would dephosphorylate SSXB9, thereby keeping it in an activated state. | ||||||